DGFT Issues New Directive On RCMC For Medical Devices To Avail Benefits Under RODTEP Scheme

Mumbai: The Directorate General of Foreign Trade (DGFT), under the Union ministry of commerce & industry, has issued a directive addressing the issuance of Registration-Cum-Membership Certificate (RCMC) for medical devices. This directive is aimed at resolving the difficulties faced by the medical device industry in obtaining the necessary certifications for export benefits under the Remission of Duties and Taxes on Exported Products (RODTEP) scheme.

The DGFT’s Public Notice No. 18/2023 dated June 23, 2023, included the Export Promotion Council (EPC) for Medical Devices in Appendix 2T of the Foreign Trade Policy (FTP) 2023. This inclusion was meant to authorize the EPC for Medical Devices to issue RCMCs for specific items, with existing RCMCs issued by Engineering Export Promotion Council of India (EEPC India) remaining valid until their expiry.

The EPC for medical devices has not yet begun regular operations or integrated into the DGFT’s Common Digital Platform for issuing RCMCs. This has caused significant delays and complications for the medical device industry in obtaining the mandatory RCMC required for export benefits and customs clearance.

To mitigate these issues, DGFT has decided that until the EPC for medical devices becomes fully operational, RCMCs can be issued by the EEPC India and any other relevant EPC for medical devices. This temporary measure is intended to facilitate smoother operations for the medical device industry.

EEPC India is the trade and investment promotion organization for the engineering sector sponsored by the Union ministry of commerce & industry. Set up in 1955, EEPC India now has a membership base of over 12,000 out of whom 60% are SMEs.

Customs authorities have been requested to accept RCMCs issued by EEPC India and any other concerned EPC for medical devices until further notice. This directive aims to ensure that medical device exports continue without unnecessary hindrances.

This decision, approved by the competent authority, is expected to provide immediate relief to the medical device industry, ensuring continued access to export benefits and smoother customs processes.

This announcement reflects the Union ministry of commerce & industry’s commitment to supporting the medical device sector and addressing the challenges faced by exporters. The interim measures will remain in place until the EPC for medical devices is fully functional, ensuring that the industry’s export activities are not disrupted.

Related Posts

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

According to the US FDA’s latest enforcement report, the recall was initiated after black spots were found on the tablets due to burnt excipient used for manufacturing. New Delhi: Sun…

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

New Delhi: The Delhi Police Crime Branch has busted an alleged illegal network involved in the smuggling, adulteration and distribution of counterfeit and unauthorised anti-cancer and other life-saving medicines in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

Sun Pharma recalls over 1900 bottles of epilepsy drug in US

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

Delhi Police Bust Illegal Network Smuggling Counterfeit and Unauthorised Anti-Cancer Medicines in Delhi-NCR

Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

Pharmacy worker arrested for illegally supplying prescription drugs, ₹4.8 lakh worth of drugs seized

Meiji Seika to push new vaccine with SII in India

Meiji Seika to push new vaccine with SII in India

DGFT automates EO extension process to ease compliance for pharma exporters

DGFT automates EO extension process to ease compliance for pharma exporters

Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark